• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health Funding Plunges in 2023, Setting Stage for 2024 Reckoning

by Fred Pennic 01/10/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– The year 2023 saw a stark shift in the digital health funding landscape, according to Rock Health’s annual year-end digital health funding report. Gone were the days of exuberant funding rounds and endless optimism.

– Instead, we witnessed a contraction, with venture capital drying up and startups scrambling to stay afloat. But amidst the turbulence, there were also signs of resilience, innovation, and a necessary course correction.

2023: A Year of Transition and Creative Measures

  • Funding Plunges: Annual digital health venture funding reached a four-year low of $10.7B, with fewer deals and smaller amounts.
  • M&A Activity Remains Muted: Despite expectations of a surge in acquisitions, the pace remained surprisingly slow.
  • No Startup Apocalypse: While shutdowns were anticipated, most companies managed to weather the storm through creative financing tactics like extension rounds, unlabeled raises, and even “silent deals” with existing investors.
  • IPO drought: No digital health companies went public in 2023, adding to the uncertainty.

2024: Facing Reality and Embracing Change

  • Labeled Rounds Return, But with Adjustments: Startups that bought time in 2023 will need to raise again, likely at lower valuations and with a renewed focus on outcomes and commercial viability.
  • M&A Takes Center Stage: Expect to see more mergers and acquisitions, as cash-strapped companies seek exits and larger players consolidate the market.
  • Public Market Recalibration: Delistings are likely for struggling companies, while strong performers may finally aim for IPOs, leading to a more stable public health tech sector.
  • Tough Choices and New Beginnings: Some startups will close their doors, but their talent and ideas will live on, potentially fueling new ventures or innovations within established companies.
  • Emerging Segments Take Flight: Areas like digital obesity care and value-based care enablement, which saw early traction in 2023, could become the next big thing in 2024.

The Road Ahead: A More Efficient and Sustainable Ecosystem

The coming year will be a period of reckoning for the digital health industry. While some may see it as a harsh reality check, it’s also an opportunity for a much-needed reset. By weeding out weaker players and forcing innovation through resourcefulness, 2024 could pave the way for a more efficient, sustainable, and ultimately, more impactful digital health ecosystem.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Digital Health Funding, Rock Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |